The support is amazing
Daily oral dosing, particularly FOUNDAYOs restriction-free take it anytime convenience, may prove to have significantly better long-term adherence profiles than weekly injections, which require patients to self-inject, rotate injection sites, and manage sharps disposal
FAQ What most articles get wrong about Jardiance and weight loss The most common error in online content about Jardiance and weight loss is treating SGLT2 inhibitors as a "natural alternative" or "gentler option" compared to GLP-1 medications
Doctronic.ai is revolutionizing healthcare by offering AI-powered primary care that is fast, smart, and personal
The dual-agonist question One theoretical question that researchers have not fully addressed is whether tirzepatide's GIP activation creates any additional considerations during breastfeeding
Disclosures Sanjay Kalra has received speaker fees from Eli Lilly, Novo Nordisk and Sanofi and is a member of the journals Editorial Board